Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05699200 · ClinicalTrials.gov registry record · NA
A Study to Analyze the Role of Sympathetic Nervous System in Spontaneous Coronary Artery Dissection
A NA study of Healthy and Spontaneous Coronary Artery Dissection, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05699200: Recruiting NA study of Healthy and Spontaneous Coronary Artery Dissection, sponsored by Mayo Clinic.
NCT05699200 is a NA study of Healthy and Spontaneous Coronary Artery Dissection that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 50 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05699200, a NA study of Healthy and Spontaneous Coronary Artery Dissection, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to compare sympathetic function (flight or fight system) and arterial health including structure and mechanics of participants with history of spontaneous coronary artery dissection (SCAD) to age and sex matched control participants.
Primary Outcome
Measured by carotid ultrasound intimal media thickness reporting in mm
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Echocardiogram
- OTHER Arterial Tonometry
- DIAGNOSTIC_TEST Carotid Ultrasounds
- DIAGNOSTIC_TEST Elastography
- OTHER Ankle-Brachial Index
Study Locations (1)
Minnesota
- Mayo Clinic Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2027-08 |
| Phase | NA |
What NCT05699200 shows while recruiting
NCT05699200 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 5 interventions - of which Echocardiogram is the first listed.
NCT05699200 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05699200 about?
NCT05699200 is a clinical study titled "A Study to Analyze the Role of Sympathetic Nervous System in Spontaneous Coronary Artery Dissection". The purpose of this research is to compare sympathetic function (flight or fight system) and arterial health including structure and mechanics of participants with history of spontaneous coronary artery dissection (SCAD) to age and sex matched control participants.
What is the current status of trial NCT05699200?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-06-01. Estimated completion is 2027-08.
What conditions does trial NCT05699200 study?
This clinical trial studies the following conditions: Healthy, Spontaneous Coronary Artery Dissection.
What interventions are being tested in trial NCT05699200?
The interventions under investigation include: Echocardiogram (DIAGNOSTIC_TEST), Arterial Tonometry (OTHER), Carotid Ultrasounds (DIAGNOSTIC_TEST), Elastography (DIAGNOSTIC_TEST), Ankle-Brachial Index (OTHER).
Who is sponsoring clinical trial NCT05699200?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05699200 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05699200's enrollment target sits among peer trials
50 448th of 1090 higher than 618 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
- NCT01746836 · 50 participants · Phase 2
Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI